Asbestos & Mesothelioma Studies

Drug Factories to Treat Mesothelioma

Researchers from Rice University and Baylor College of Medicine developed a new treatment that can eliminate advanced stage mesothelioma tumors in mice within days. The breakthrough treatment used Rice’s cytokine drug factory implants with a checkpoint inhibitor drug. This combination is showing great potential in mesothelioma preclinical trials. The treatment[…]

Read More »

Decision Making Tools for Mesothelioma

Mesothelioma, a cancer mainly caused by asbestos exposure, is very rare and aggressive. There are many challenges that doctors face when diagnosing, treating, and managing this cancer. Advances in medical technology and data analytics are helping doctors make crucial decisions for patients struggling with the hard to treat and deadly[…]

Read More »

MARS 2 Trial for Mesothelioma

Malignant pleural mesothelioma is a deadly cancer mainly caused by asbestos exposure. It is a hard-to-treat cancer due to its aggressiveness. The cancer affects the pleura, which is the membrane that covers the lungs. A trial known as MARS 2 tried to find out if extended pleurectomy and decortication could[…]

Read More »

New Blood Test for Mesothelioma

Mayo Clinic researchers have created a new blood test that is better able to detect mesothelioma. The result could be earlier diagnoses. It could also lead to new options for targeted therapies. The test works by finding complex DNA patterns that are common in mesothelioma cells. The new approach is[…]

Read More »

Immune Checkpoint Inhibitors for the Treatment of Mesothelioma

Mesothelioma is a rare, aggressive cancer mainly caused by asbestos exposure. One treatment that is giving hope to patients and caregivers is the use of immune checkpoint inhibitors. A new study from Australia has raised questions about the effectiveness and safety of this novel treatment. In order to best care[…]

Read More »

CAR-T Cell Therapy for Mesothelioma

Mesothelioma is a rare, yet aggressive cancer mainly caused by asbestos exposure. There are very limited options for treatment. This is especially true for elderly patients. Conventional therapies might not be the best option due to the person’s age and other health problems. Chimeric antigen receptor (CAR) T cell therapy[…]

Read More »

Keytruda and Chemotherapy Improve Survival in Mesothelioma Patients

The U.S Food and Drug Administration has accepted a priority review for a new Supplemental Biologics License Application. This could be a new era in the management of pleural mesothelioma, leading to a better future for those diagnosed with the cancer. The review is looking for approval of Keytruda used[…]

Read More »

Palliative Care Improves Lives of Mesothelioma Patients

Palliative care is an essential part of the cancer treatment process. It helps improve the quality of life of people with life threatening illnesses like mesothelioma. It is important for doctors to know the range of symptoms patients experience to help provide the best care possible. Palliative care is a[…]

Read More »